Fiscal year ending 2021. Filed on January 24, 2022.
1420 K Street NW 7th Floor
Washington, District of Columbia 20005
Melanoma Research Foundation Breakthrough Consortium Inc. (EIN: 80-0671049) has filed an IRS Form 990 from fiscal year 2017–2021. In its fiscal year 2021 IRS Form 990 filing, Melanoma Research Foundation Breakthrough Consortium Inc., a 501(c)(3) charitable organization, reported compensation for 0 out of 0 total employees.
Revenue
Expenses
Employee compensation
No compensated employees were reported for this year.
THE MISSION OF THE MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM, INC. (THE CONSORTIUM) IS TO ACCELERATE THE RESEARCH AND DEVELOPMENT OF THE MOST PROMISING THERAPEUTICS IN MELANOMA IN ORDER TO DELIVER CURATIVE OPTIONS TO PATIENTS. THE CONSORTIUM WILL DEVELOP COLLABORATIVE, MULTI-SECTOR PARTNERSHIPS ACROSS THE BREADTH OF MELANOMA DISCIPLINES - BASIC, TRANSLATIONAL AND CLINICAL SCIENCE - TO EXPEDITE DEVELOPMENT OF COMBINATIONS OF THERAPIES AS WELL AS NOVEL SINGLE AGENTS; SUPPORT PRE-CLINICAL RESEARCH TO FACILITATE RATIONAL COMBINATIONS; CREATE A VIRTUAL ANNOTATED SPECIMEN BIOREPOSITORY; AND IDENTIFY BIOMARKERS THAT HAVE PROGNOSTIC AND PREDICTIVE VALUE OR VALUE AS A NEW THERAPEUTIC TARGET.
Be the first to know when new IRS Form 990 data is published for this organization.